Preventing stroke

British Medical Journal

Volumn 324, Issue 7339, 2002, Pages 687-688

  Schrader, Joachim ^a   Lüders, Stephan ^a  

^a ST JOSEFS HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN ANTAGONIST; RAMIPRIL;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; DRUG COST; EDITORIAL; HEALTH CARE COST; HYPERTENSION; INFLAMMATION; OUTCOMES RESEARCH; OXIDATIVE STRESS; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 0037160916     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.324.7339.687     Document Type: Editorial

References (8)

1. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
2. Use of ramipril in preventing stroke: Double blind randomised trial
3. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
4. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack
5. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection
6. Improved endothelial function with angiotensin-converting enzyme inhibitors
7. Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure?